Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer NM Desouza, SF Riches, NJ Vanas, VA Morgan, SA Ashley, C Fisher, ... Clinical radiology 63 (7), 774-782, 2008 | 314 | 2008 |
Combined Use of Diffusion-Weighted MRI and 1H MR Spectroscopy to Increase Accuracy in Prostate Cancer Detection SA Reinsberg, GS Payne, SF Riches, S Ashley, JM Brewster, VA Morgan, ... American Journal of Roentgenology 188 (1), 91-98, 2007 | 243 | 2007 |
A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance NJ van As, NM de Souza, SF Riches, VA Morgan, SA Sohaib, ... European urology 56 (6), 981-988, 2009 | 190 | 2009 |
Diffusion‐weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients SF Riches, K Hawtin, EM Charles‐Edwards, NM De Souza NMR in Biomedicine: An International Journal Devoted to the Development and …, 2009 | 189 | 2009 |
Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images K Downey, SF Riches, VA Morgan, SL Giles, AD Attygalle, TE Ind, ... American Journal of Roentgenology 200 (2), 314-320, 2013 | 166 | 2013 |
MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters SF Riches, GS Payne, VA Morgan, S Sandhu, C Fisher, M Germuska, ... American journal of roentgenology 193 (6), 1583-1591, 2009 | 124 | 2009 |
Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance VA Morgan, SF Riches, K Thomas, N Vanas, C Parker, S Giles, ... The British journal of radiology 84 (997), 31-37, 2011 | 113 | 2011 |
Nine-year follow-up for a study of diffusion-weighted magnetic resonance imaging in a prospective prostate cancer active surveillance cohort DR Henderson, NM de Souza, K Thomas, SF Riches, VA Morgan, ... European urology 69 (6), 1028-1033, 2016 | 90 | 2016 |
Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy VA Morgan, SF Riches, S Giles, D Dearnaley, NM deSouza American Journal of Roentgenology 198 (3), 596-602, 2012 | 81 | 2012 |
Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components SL Giles, VA Morgan, SF Riches, K Thomas, C Parker, NM deSouza American Journal of Roentgenology 196 (3), 586-591, 2011 | 73 | 2011 |
Relationship between T 2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional … CJ Simpkin, VA Morgan, SL Giles, SF Riches, C Parker, NM DeSouza The British Journal of Radiology 86 (1024), 20120469, 2013 | 47 | 2013 |
Measurements of occupational exposure to switched gradient and spatially‐varying magnetic fields in areas adjacent to 1.5 T clinical MRI systems SF Riches, DJ Collins, GD Charles‐Edwards, JC Shafford, J Cole, ... Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2007 | 42 | 2007 |
Multivariate modelling of prostate cancer combining magnetic resonance derived T2, diffusion, dynamic contrast-enhanced and spectroscopic parameters SF Riches, GS Payne, VA Morgan, D Dearnaley, S Morgan, M Partridge, ... European Radiology 25, 1247-1256, 2015 | 39 | 2015 |
Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters SF Riches, GS Payne, NM Desouza, D Dearnaley, VA Morgan, ... The British journal of radiology 87 (1037), 20130813, 2014 | 37 | 2014 |
EU Directive 2004/40: field measurements of a 1.5 T clinical MR scanner SF Riches, DJ Collins, JW Scuffham, MO Leach The British Journal of Radiology 80 (954), 483-487, 2007 | 37 | 2007 |
Validation of T2-and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated … EJ Alexander, JR Murray, VA Morgan, SL Giles, SF Riches, S Hazell, ... Radiotherapy and Oncology 141, 181-187, 2019 | 17 | 2019 |
Nine-year follow-up for a study of diffusion-weighted MRI in a prospective active surveillance cohort for prostate cancer. DR Henderson, NM DeSouza, K Thomas, VA Morgan, SF Riches, ... Journal of Clinical Oncology 33 (15_suppl), 5043-5043, 2015 | 2 | 2015 |
Optimal combined functional MR parameters to correctly identify tumour in the prostate S Riches, GS Payne, M Partridge, C Jameson, V Morgan Proc Intl Soc Mag Reson Med 44, 100, 2013 | 2 | 2013 |
Modelling Diffusion Data using a Stretched-Exponential Model: Pitfalls in Estimation Methodology M Orton, D Collins, S Riches, M Leach Prostate 1, 1.2, 2007 | 2 | 2007 |
Planning a boosted ra-diotherapy dose to the dominant intraprostatic tumour lesion within the prostate as defined by multifunctional MR parameters SF Riches, GS Payne, NM DeSouza, S Morgan, D Dearnaley, V Morgan, ... ISMRM, Salt Lake city, USA 100, 2013 | 1 | 2013 |